A newly developed clinical treatment for veterans suffering from Moral Injury will enter into a second phase of testing.

This research project will examine if it is feasible and acceptable to pilot a Randomised Controlled Trial (RCT) of ‘Restore & Rebuild’ (R&R) treatment compared to a Treatment as Usual (TAU) control group of UK veterans with Moral Injury (MI)-related mental disorders. This will be completed using mixed-methods to test the feasibility of conducting a pilot RCT of R&R treatment in UK veterans with Moral Injury-related mental ill-health.

FiMT had previously funded a team from King’s College London and the veterans’ mental health charity Combat Stress to develop and pilot a new treatment to support veterans with Moral Injury. This trial was successful and FiMT has awarded the research a further £261,941 to conduct a randomised controlled trial to formally evaluate this new treatment.

In the preceding study, the researchers developed ‘Restore and Rebuild’ – a treatment for Moral Injury. It was co-produced with veterans and subject matter experts, then successfully piloted with 20 veterans. This second phase will test the feasibility of a pilot to compare the Restore and Rebuild treatment to a control group of UK veterans with Moral Injury-related mental disorders.